DACFORLY
LIVE

Serial Number

99376250

Owner

Glaxo Group Limited

Attorney

Christopher M. Hanes

Filing Date

Sep 5, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DACFORLY Trademark

Serial Number: 99376250 • Registration: 8212172

DACFORLY is a trademark filed by Glaxo Group Limited on September 5, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Glaxo Group Limited (128 trademarks)

GSK Medicines Research Centre
Stevenage SG12NY , GB

Entity Type: 77

Trademark Details

Filing Date

September 5, 2025

Registration Date

April 14, 2026

Published for Opposition

February 24, 2026

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 14, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 14, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 18, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2026 CNSA
ASSIGNED TO EXAMINER
Jan 21, 2026 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jan 20, 2026 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 20, 2026 PARI
APPLICATION FILING RECEIPT MAILED
Sep 5, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 5, 2025 NWOS
NEW APPLICATION ENTERED
Sep 5, 2025 NWAP